CIK 0001991792 · Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371611499
- Phone
- (949) 409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $135,045
- in 2 filings, $135K under 10b5-1 plans
Net −$135,045. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-17 | Mulay James Director | Sale 10b5-1 | −15,600 | $73.01 | $1.1M | 0 |
| 2026-04-17 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −15,600 | 0 | ||
| 2026-04-15 | Bellete Ambaw President and COO | Grant or award · Employee Stock Option (Right to Buy) | +107,508 | 107,508 | ||
| 2026-04-15 | Kasturi Vijay Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +79,216 | 79,216 | ||
| 2026-04-15 | Patterson Joshua F. See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +45,266 | 45,266 | ||
| 2026-04-15 | DETORE JAMES M. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +90,574 | 90,574 | ||
| 2026-04-15 | Kuan Arthur Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +271,600 | 271,600 | ||
| 2026-03-16 | Mulay James Director | Option exercise 10b5-1 | +654 | $3.72 | $2K | 654 |
| 2026-03-16 | Mulay James Director | Sale 10b5-1 | −654 | $63.50 | $42K | 0 |
| 2026-03-16 | Mulay James Director | Option exercise 10b5-1 | +1,310 | $12.59 | $16K | 1,310 |
| 2026-03-16 | Mulay James Director | Sale 10b5-1 | −1,310 | $63.50 | $83K | 0 |
| 2026-03-16 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −654 | 654 | ||
| 2026-03-16 | Mulay James Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −1,310 | 3,930 | ||
| 2026-03-12 | Kuan Arthur Chief Executive Officer | Option exercise | +64,612 | $1.72 | $111K | 200,763 |
| 2026-03-12 | Kuan Arthur Chief Executive Officer | Shares withheld for taxes | −1,847 | $60.15 | $111K | 198,916 |
| 2026-03-12 | Kuan Arthur Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −64,612 | 0 | ||
| 2026-03-04 | Kuan Arthur Chief Executive Officer | Option exercise | +102,871 | $1.72 | $177K | 139,022 |
| 2026-03-04 | Kuan Arthur Chief Executive Officer | Shares withheld for taxes | −2,871 | $61.61 | $177K | 136,151 |
| 2026-03-04 | Kuan Arthur Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) | −102,871 | 64,612 | ||
| 2026-01-09 | Mulay James Director | Option exercise 10b5-1 | +654 | $3.72 | $2K | 654 |
Page 3 of 9 · 172 trades